<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMJ Open Diabetes Res Care</journal-id><journal-id journal-id-type="iso-abbrev">BMJ Open Diabetes Res Care</journal-id><journal-id journal-id-type="hwp">bmjdrc</journal-id><journal-id journal-id-type="publisher-id">bmjdrc</journal-id><journal-title-group><journal-title>BMJ Open Diabetes Research &#x00026; Care</journal-title></journal-title-group><issn pub-type="epub">2052-4897</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name><publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28989726</article-id><article-id pub-id-type="pmc">5604719</article-id><article-id pub-id-type="publisher-id">bmjdrc-2017-000440</article-id><article-id pub-id-type="doi">10.1136/bmjdrc-2017-000440</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Care/Education/Nutrition</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1506</subject></subj-group></article-categories><title-group><article-title>Carbohydrate-last meal pattern lowers postprandial glucose and insulin excursions in type 2 diabetes</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Shukla</surname><given-names>Alpana P</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Andono</surname><given-names>Jeselin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Touhamy</surname><given-names>Samir H</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Casper</surname><given-names>Anthony</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Iliescu</surname><given-names>Radu G</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Mauer</surname><given-names>Elizabeth</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Shan Zhu</surname><given-names>Yuan</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Ludwig</surname><given-names>David S</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Aronne</surname><given-names>Louis J</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<institution content-type="department">Comprehensive Weight Control Center, Division of Endocrinology, Diabetes, &#x00026; Metabolism</institution>, <institution>Weill Cornell Medical College</institution>, <addr-line content-type="city">New York</addr-line>, <addr-line content-type="state">NY</addr-line>, <country>USA</country>
</aff><aff id="aff2">
<label>2</label>
<institution>Institute of Human Nutrition, Columbia University</institution>, <addr-line content-type="city">New York</addr-line>, <country>USA</country>
</aff><aff id="aff3">
<label>3</label>
<institution content-type="department">Department of Healthcare Policy and Research</institution>, <institution>Weill Cornell Medical College</institution>, <addr-line content-type="state">New York</addr-line>, <country>USA</country>
</aff><aff id="aff4">
<label>4</label>
<institution content-type="department">Department of Medicine</institution>, <institution>Clinical and Translational Science Center, Weill Cornell Medical College</institution>, <addr-line content-type="city">New York</addr-line>, <country>USA</country>
</aff><aff id="aff5">
<label>5</label>
<institution content-type="department">The New Balance Foundation Obesity Prevention Center, Department of Medicine</institution>, <institution>Boston Children&#x02019;s Hospital</institution>, <addr-line content-type="city">Boston</addr-line>, <addr-line content-type="state">Massachusetts</addr-line>, <country>USA</country>
</aff><author-notes><corresp><label>Correspondence to</label> Dr&#x000a0;Alpana P&#x000a0;Shukla; <email>aps2004@med.cornell.edu</email></corresp></author-notes><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>14</day><month>9</month><year>2017</year></pub-date><volume>5</volume><issue>1</issue><elocation-id>e000440</elocation-id><history><date date-type="received"><day>09</day><month>5</month><year>2017</year></date><date date-type="rev-recd"><day>08</day><month>8</month><year>2017</year></date><date date-type="accepted"><day>14</day><month>8</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access"><license-p>This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link></license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="bmjdrc-2017-000440.pdf"/><abstract><sec><title>Background</title><p>There are limited data regarding the timing of carbohydrate ingestion during a meal and postprandial glucose regulation.</p></sec><sec><title>Methods</title><p>Sixteen subjects with type 2 diabetes mellitus (T2DM) consumed the same meal on 3 days in random order: carbohydrate first, followed 10&#x02009;min later by protein and vegetables; protein and vegetables first, followed 10&#x02009;min later by carbohydrate; or all components together. Blood was sampled for glucose, insulin, glucagon-like peptide-1 (GLP-1), and glucagon measurements at baseline (just before meal ingestion) and subsequently at 30&#x02009;min intervals up to 180&#x02009;min.</p></sec><sec><title>Results</title><p>The incremental areas under the curve for glucose (iAUC<sub>0&#x02013;180</sub>) and incremental glucose peaks were 53% and 54%&#x02009;lower, respectively, when carbohydrate was consumed last compared with carbohydrate consumed first (3124.7&#x000b1;501.2 vs 6703.5&#x000b1;904.6&#x02009;mg/dL&#x000d7;180min, p&#x0003c;0.001; 34.7&#x000b1;4.1 vs 75.0&#x000b1;6.5&#x02009;mg/dL, p&#x0003c;0.001) and 44% and 40%&#x02009;lower, respectively, compared with the all components together condition (3124.7&#x000b1;501.2 vs 5587.1&#x000b1;828.7&#x02009;mg/dL&#x000d7;180min, p=0.003; 34.7&#x000b1;4.1 vs 58.2&#x000b1;5.9&#x02009;mg/dL, p&#x0003c;0.001). Postprandial insulin excursions were lower (iAUC<sub>0&#x02013;180</sub>: 7354.1&#x000b1;897.3 vs 9769.7&#x000b1;1002.1&#x02009;&#x000b5;U/mL&#x000d7;min, p=0.003) and GLP-1 excursions higher (iAUC<sub>0&#x02013;180</sub>: 3487.56&#x000b1;327.7 vs 2519.11&#x000b1;494.8&#x02009;pg/mL&#x000d7;min, p=0.019) following the carbohydrate-last meal order compared with carbohydrate first.</p></sec><sec><title>Conclusion</title><p>The carbohydrate-last meal pattern may be an effective behavioral strategy to improve postprandial glycemia.</p></sec></abstract><kwd-group><kwd>Dietary Intervention</kwd><kwd>Eating Behavior(s)</kwd><kwd>Postprandial Glycemia</kwd><kwd>Postprandial Glucose Regulation</kwd></kwd-group><funding-group><award-group id="funding-1"><funding-source><institution-wrap><institution>Clinical and Translational Science Center at Weill Cornell Medical College</institution></institution-wrap></funding-source></award-group><award-group id="funding-2"><funding-source><institution-wrap><institution>Rachel and Louis Rudin Foundation</institution></institution-wrap></funding-source></award-group><award-group id="funding-3"><funding-source><institution-wrap><institution>Diane and Darryl Mallah</institution></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>special-feature</meta-name><meta-value>unlocked</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text id="B1" position="float" orientation="portrait"><caption><title>Significance of this study</title></caption><sec><title>What is already known about this subject?</title><list list-type="bullet"><list-item><p>Limited data on nutrient order during a meal suggests that&#x000a0;consuming carbohydrate last lowers postprandial glucose excursions compared to carbohydrate consumed first. Protein preload stimulates insulin and incretin hormone secretion resulting in a lower postprandial glucose response.</p></list-item></list></sec><sec><title>What are the new findings?</title><list list-type="bullet"><list-item><p>The carbohydrate-last meal pattern reduced postprandial glucose excursions compared to consuming carbohydrate first or all meal components together.</p></list-item><list-item><p>In contrast to protein preloads, the carbohydrate-last meal pattern lead to lower glycemic and insulin excursions but higher glucagon-like peptide-1 response.</p></list-item></list></sec><sec><title>Current research questions?</title><list list-type="bullet"><list-item><p>Generalizability to meals with different macronutrient composition and different subsets of patients, for&#x000a0;example, Type&#x000a0;1, prediabetes</p></list-item><list-item><p>Effect of the sequence of nutrient ingestion on gastric emptying and rates of nutrient absorption</p></list-item></list></sec><sec><title>How might these results change the focus of research or clinical practice?</title><list list-type="bullet"><list-item><p>The carbohydrate-last meal pattern may be an effective behavioral strategy to improve postprandial glucose control in patients with type 2 diabetes&#x000a0;mellitus; feasibility and effectiveness need to be assessed in prospective studies.</p></list-item></list></sec></boxed-text><p>Postprandial hyperglycemia is an independent risk factor for both macrovascular<xref rid="R1" ref-type="bibr">1</xref> and microvascular<xref rid="R2" ref-type="bibr">2</xref> complications of type 2 diabetes mellitus (T2DM) and is the major determinant of glucose control at glycated hemoglobin&#x000a0;(HbA1c) values below 7.3%.<xref rid="R3" ref-type="bibr">3</xref> Current nutritional strategies to attenuate postprandial glucose excursions are based on the quantity and type of carbohydrate consumed as the primary predictors of glycemic response. Beyond carbohydrate type and amount, postmeal glucose excursions can be attenuated by fat and protein preloads<xref rid="R4" ref-type="bibr">4&#x02013;7</xref> and by a modified macronutrient composition that includes more protein<xref rid="R8" ref-type="bibr">8</xref> and dietary fiber.<xref rid="R9" ref-type="bibr">9</xref>
</p><p>A study in eight subjects with T2DM demonstrated that whey protein consumed before a carbohydrate meal can stimulate insulin and incretin hormone secretion and slow gastric emptying, leading to marked reduction in postprandial glycemia.<xref rid="R6" ref-type="bibr">6</xref> These findings were confirmed in a subsequent study of 15 subjects that showed a 28% reduction in postprandial glucose excursions over 180&#x02009;min that was accompanied by an increase in glucagon-like peptide-1&#x000a0;(GLP-1) and insulin responses.<xref rid="R7" ref-type="bibr">7</xref> The addition of whey to meals with rapidly digested and absorbed carbohydrates has also been shown to stimulate insulin release and reduce postprandial blood glucose excursion by 21% after a lunch meal consisting of mashed potatoes and meatballs in subjects with T2DM.<xref rid="R4" ref-type="bibr">4</xref>
</p><p>There are limited data, however, regarding the impact of the temporal sequence of carbohydrate ingestion during a meal on postprandial glycemia.<xref rid="R10" ref-type="bibr">10 11</xref> In a previous pilot study of 11 patients with metformin-treated T2DM, we demonstrated that ingestion of protein and vegetables before carbohydrate led to lower postprandial glucose and insulin excursions for 120&#x02009;min, compared with eating the same foods in the reverse order.<xref rid="R11" ref-type="bibr">11</xref> No study has investigated the effects of the timing of carbohydrate ingestion during a meal on postprandial glucose, insulin and incretin hormone excursions.</p><p>The aim of this study was to determine the optimal timing of carbohydrate ingestion during a meal that can lower postprandial glycemia in the setting of three real-world meal conditions and additionally explore the effect of food order on insulin and incretin hormone excursions. We postulated that consuming vegetables and protein together as the first course instead of carbohydrate would result in lower post-meal glucose excursions compared with the reverse order and consuming all meal components&#x000a0;(protein, vegetables and carbohydrate) all together would result in intermediate effects.</p><sec id="s1"><title>Research design and methods</title><sec id="s1a"><title>Subject inclusion and exclusion criteria</title><p>Male and female participants between 35&#x000a0;and&#x000a0;65 years of age, body mass index (BMI) 25&#x02013;40&#x02009;kg/m<sup>2</sup> and metformin-treated T2DM of less than 10 years duration with HbA1c&#x000a0;&#x02264;8% were included in the study.</p><p>Patients taking corticosteroids, antidiabetic medication other than metformin, and patients with chronic renal or hepatic disease or history of prior bariatric surgery were excluded. The study was approved by the Weill Cornell Medical College Institutional Review Board (IRB#1502015945). All participants gave written informed consent.</p></sec><sec id="s1b"><title>Study protocol</title><p>We used a crossover design in which all participants consumed isocaloric meals (<xref ref-type="table" rid="T1">table 1</xref>) of the same composition on three separate days, 1&#x02009;week apart, after a 12&#x02009;hours overnight fast. Participants were instructed to maintain their usual level of physical activity and diet throughout the study period and in particular the day prior to each test session. All meals were prepared in the metabolic kitchen of the Clinical and Translational Science Center at Weill Cornell Medical College. Each meal was consumed in 30&#x02009;min, under the following conditions that were randomly assigned using research randomizer:<list list-type="order"><list-item><p>Carbohydrate first (CF) (ciabatta bread and orange juice) over&#x000a0;10&#x02009;min, a 10&#x02009;min rest interval, and then protein (skinless grilled chicken breast) and vegetables (lettuce, tomatoes and cucumber with Italian vinaigrette) over&#x000a0;10&#x02009;min.</p></list-item><list-item><p>Protein and vegetables first over 10 min, a 10&#x02009;min rest interval, and then carbohydrate over 10 min (carbohydrate last&#x000a0;(CL)).</p></list-item><list-item><p>All meal components together as a sandwich with each half consumed with half the orange juice over 10&#x02009;min and a 10&#x02009;min interval in between (sandwich&#x000a0;(S)).</p></list-item></list>
</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Meal composition</p></caption><table frame="hsides" rules="groups"><tbody><tr><td valign="bottom" colspan="2" align="left" rowspan="1">Orange juice&#x000a0;(no pulp)</td><td valign="bottom" colspan="2" align="char" char="." rowspan="1">120 g</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">Ciabatta bread</td><td colspan="2" align="char" char="." rowspan="1">90 g</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">Butter (unsalted)</td><td colspan="2" align="char" char="." rowspan="1">5&#x000a0;g</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">Chicken breast&#x000a0;(skinless, flame grilled)</td><td colspan="2" align="char" char="." rowspan="1">150 g</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">Lettuce&#x000a0;(Romaine)</td><td colspan="2" align="char" char="." rowspan="1">45 g</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">Tomatoes</td><td colspan="2" align="char" char="." rowspan="1">50 g</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">Cucumber&#x000a0;(with skin)</td><td colspan="2" align="char" char="." rowspan="1">75 g</td></tr><tr><td valign="top" colspan="2" align="left" rowspan="1">Salad dressing&#x000a0;(Italian, fat free)</td><td colspan="2" align="char" char="." rowspan="1">15 g</td></tr><tr><td align="left" rowspan="1" colspan="1">Calories (kJ)</td><td align="left" rowspan="1" colspan="1">Protein (g)</td><td align="left" rowspan="1" colspan="1">Fat (g)</td><td align="left" rowspan="1" colspan="1">Carbohydrate (g)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;2403.42</td><td align="left" rowspan="1" colspan="1">55.30</td><td align="left" rowspan="1" colspan="1">9.62</td><td align="left" rowspan="1" colspan="1">64.47</td></tr></tbody></table></table-wrap><p>Participants were closely monitored to ensure that all meals were consumed in their entirety within the allotted time. Blood samples were drawn from an in-dwelling venous cannula at baseline (just before meal ingestion) and at 30&#x02009;min intervals up to 180&#x02009;min after the start of the meal. Glucose concentrations were assessed in whole blood using a quantitative enzymatic photometry cassette from Alere (San Diego, California, USA). The intra-assay and inter-assay coefficients of variation are&#x000a0;&#x02264;6.2%&#x02009;and&#x02264;5.0%, respectively. The plasma concentrations of insulin and glucagon were determined using quantitative immunoradiometric assay kits from Millipore (St. Charles, Missouri, USA). The intra-assay and inter-assay coefficients of variation are &#x02264;4.4%&#x02009;and &#x02264;6.0% for insulin and&#x000a0;&#x02264;4.8%&#x02009;and&#x02264;6.4% for glucagon, respectively. The measurement range is 3.125&#x02013;200.0 &#x000b5;U/mL for insulin and 4.7&#x02013;150&#x02009;pmol/L for glucagon. The plasma concentration of active GLP-1 was determined using an electrochemiluminescent assay kit from Meso Scale Diagnostics (Rockville, Maryland, USA) with collection of blood samples in the BD P800 blood collection tube containing a proprietary cocktail of protease, esterase and dipeptidyl peptidase&#x000a0;IV inhibitors which provides immediate protection of bioactive peptides from degradation in plasma. The intra-assay and inter-assay coefficients of variation are &#x02264;11.2%&#x02009;and &#x02264;13.4%, respectively, and the measurement range is 0.24&#x02013;1000&#x02009;pg/mL.</p></sec><sec id="s1c"><title>Statistical analysis</title><p>Demographics for participants were described as mean&#x000b1;SD. Glucose, insulin, iGLP-1 and glucagon concentrations (at time intervals of interest) and their respective incremental areas under the curves&#x000a0;(iAUCs) at 180&#x02009;min were described as mean&#x000b1;SEM for each group. Incremental glucose peaks were also described as mean&#x000b1;SEM. Linear mixed effects models accounting for correlation within the same participant were implemented for each outcome of interest to compare the three groups. Post-hoc analyses were performed by Tukey's method with Bonferroni adjustment. p Values were two-sided with statistical significance evaluated at the 0.05 alpha level or the Bonferroni-corrected 0.05 alpha level, where applicable. Analyses were performed in R V.3.4.0 (Vienna, Austria).</p></sec></sec><sec sec-type="results" id="s2"><title>Results</title><p>The study population included 16 participants with overweight/obesity (nine female and seven male) with T2DM on a stable dose of metformin. The average&#x000a0;(mean&#x000b1;SD) age and BMI were 57.7&#x000b1;7.6&#x02009;years and 32.8&#x000b1;3.3&#x02009;kg/m<sup>2</sup>, respectively. The average duration of diabetes among the participants was 3.8&#x000b1;2.4&#x02009;years and the mean HbA1c was 6.5%&#x000b1;0.7%. One participant did not have sandwich data; however, this participant was not lost in analyses because mixed effects models handle missing values by maximum likelihood estimation and are robust to missing random data. However, sensitivity analyses by excluding this participant did not change the significance of results.</p><p>There were no differences between baseline fasting glucose concentrations in the three meal conditions. Postprandial mean glucose concentrations were significantly decreased by 20.8%, 30.2%, and 23.1% at 30, 60, and 90&#x02009;min&#x000a0;(<xref ref-type="fig" rid="F1">figure 1</xref>), respectively, and the iAUC<sub>0&#x02013;180</sub> was 53.4% lower (3124.7&#x000b1;501.2 vs 6703.5&#x000b1;904.6&#x02009;mg/dL&#x000d7;180&#x000a0;min, p&#x0003c;0.001) following the CL meal order, compared with CF, the reverse meal order&#x000a0;(<xref ref-type="table" rid="T2">table 2</xref>). CL meal pattern showed reduced postprandial glucose levels compared with the S meal pattern: a decrease of 19.8%, 25.2%, and 15.3% at 30, 60, and 90&#x02009;min, respectively, and a decrease in iAUC<sub>0&#x02013;180</sub> of 44.1% (3124.7&#x000b1;501.2 vs 5587.1&#x000b1;828.7&#x02009;mg/dL&#x000d7;180&#x000a0;min, p=0.003). Following the CL meal order, glucose levels plateaued between 90&#x000a0;and&#x000a0;180&#x02009;min postprandially, whereas, there were marked fluctuations in glucose concentrations in the CF meal condition, with the glucose level being significantly lower than CL at 180&#x02009;min. Incremental glucose peaks were 53.8% and 40.4%&#x02009;lower for the CL meal order compared with CF and S, respectively&#x000a0;(34.7&#x000b1;4.1 vs 75.0&#x000b1;6.5&#x02009;mg/dL, p&#x0003c;0.001; 34.7&#x000b1;4.1 vs 58.2&#x000b1;5.9&#x02009;mg/dL, p&#x0003c;0.001) and 22.4% lower for S compared with CF&#x000a0;(58.2&#x000b1;5.9&#x02009;mg/dL vs 75.0&#x000b1;6.5&#x02009;mg/dL, p&#x0003c;0.001).</p><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Postprandial glucose, insulin and glucagon-like peptide-1 (GLP-1) levels following carbohydrate-first (CF), carbohydrate-last (CL) and sandwich (S) meal orders. Values are mean&#x000b1;SEM. &#x000a5;Statistically significant differences (p&#x0003c;0.05) between CF and CL. &#x00398;Statistically significant differences (p&#x0003c;0.05) between CF and S. &#x025ca;Statistically significant differences (p&#x0003c;0.05) between CL and S.</p></caption><graphic xlink:href="bmjdrc-2017-000440f01"/></fig><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Incremental areas under the curves (iAUCs) (0&#x02013;180&#x02009;min) during the three visits</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left" rowspan="1" colspan="1"/><td valign="bottom" align="left" rowspan="1" colspan="1">Time (min)&#x02020;&#x02021;</td><td valign="bottom" align="left" rowspan="1" colspan="1">Carbohydrates first (CF)</td><td valign="bottom" align="left" rowspan="1" colspan="1">Carbohydrates last (CL)</td><td valign="bottom" align="left" rowspan="1" colspan="1">Sandwich (S)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Glucose iAUC <break/>(mmol/L&#x000d7;min)*</td><td align="char" char="." rowspan="1" colspan="1">0&#x02013;180</td><td align="char" char="." rowspan="1" colspan="1">372.0&#x000b1;50.2&#x000a7;</td><td align="char" char="." rowspan="1" colspan="1">173.4&#x000b1;27.8&#x000a7;&#x000b6;</td><td align="char" char="." rowspan="1" colspan="1">310.08&#x000b1;46.0&#x000b6;</td></tr><tr><td align="left" rowspan="1" colspan="1">Insulin iAUC <break/>(pmol/L&#x000d7;min)*</td><td align="char" char="." rowspan="1" colspan="1">0&#x02013;180</td><td align="char" char="." rowspan="1" colspan="1">67850.6&#x000b1;6959.6&#x000a7;</td><td align="char" char="." rowspan="1" colspan="1">51074.2&#x000b1;6231.7&#x000a7;</td><td align="char" char="." rowspan="1" colspan="1">61541.0&#x000b1;7295.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Glucagon-like peptide-1 iAUC <break/>(pmol/L&#x000d7;min)*</td><td align="char" char="." rowspan="1" colspan="1">0&#x02013;180</td><td align="char" char="." rowspan="1" colspan="1">763.8&#x000b1;150.0&#x000a7;</td><td align="char" char="." rowspan="1" colspan="1">1057.4&#x000b1;99.4&#x000a7;</td><td align="char" char="." rowspan="1" colspan="1">956.1&#x000b1;136.3</td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p>*Values are expressed in SI units as mean&#x000b1;SEM, n=16.</p></fn><fn id="tblfn2"><p>&#x02020;Blood samples were collected immediately before the meal (t=0&#x02009;min) and at 30, 60, 90, and 180&#x02009;min after the start of the meal.</p></fn><fn id="tblfn3"><p>&#x02021;Intervals were measured in minutes from the start of the meal. The 30-minute time point was immediately collected after the meal was finished.</p></fn><fn id="tblfn4"><p>&#x000a7;Statistically significant differences (p&#x0003c;0.05) between CF and CL.</p></fn><fn id="tblfn5"><p>&#x000b6;Statistically significant differences (p&#x0003c;0.05) between CL and S.</p></fn></table-wrap-foot></table-wrap><p>The CL meal resulted in lower insulin excursions; iAUC<sub>0&#x02013;180</sub> was 24.8% lower compared with CF (7354.1&#x000b1;897.3 vs 9769.7&#x000b1;1002.1 &#x000b5;U/mL&#x000d7;180&#x000a0;min, p=0.003). The insulin excursions were not significantly different between the CF and S meal conditions&#x000a0;(7354.1&#x000b1;897.3 vs 8861.2&#x000b1;1050.5 &#x000b5;U/mL&#x000d7;180&#x000a0;min, p=0.137). The GLP-1 response to the CL meal order was greater compared with CF (3487.56&#x000b1;327.7 vs 2519.11&#x000b1;494.8&#x02009;pg/mL&#x000d7;180&#x000a0;min,&#x000a0;p=0.019)&#x000a0;and similar to the S meal condition (3487.56&#x000b1;327.7 vs 3153.2&#x000b1;449.4&#x02009;pg/mL&#x000d7;180&#x000a0;min, p=0.999). The glucagon excursions were not significantly different between the three meal conditions.</p></sec><sec sec-type="conclusions" id="s3"><title>Conclusions</title><p>In this study, we demonstrated that the temporal sequence of carbohydrate ingestion during a meal has significant impact on postprandial glucose regulation. These findings confirm and extend results from our previous pilot study<xref rid="R11" ref-type="bibr">11</xref>; the inclusion of a third nutrient order condition, a sandwich, had intermediate effects on glucose excursions compared with CL versus CF.</p><p>Previous studies investigating the effect of premeal ingestion of whey protein have demonstrated that the glucose-lowering effect is accompanied by an insulinotropic response.<xref rid="R6" ref-type="bibr">6 7</xref> In contrast, our results demonstrate that consumption of protein and vegetables first, followed by carbohydrate, reduces both postmeal glucose and insulin excursions, suggesting that the CL meal pattern requires less insulin controlling for carbohydrate amount.</p><p>Modifying the rate of nutrient absorption is a therapeutic principle of particular relevance to diabetes. A plausible explanation for the attenuated glycemic response observed with the CL meal pattern is delayed gastric emptying and consequently slower rates of carbohydrate absorption, a mechanism that would not be entirely mediated by GLP-1. The finding of lower insulin iAUC in the context of increased GLP-1 excursions contrasts with the effect of protein preloads that augment both GLP-1 and insulin secretion<xref rid="R6" ref-type="bibr">6 7 12</xref> and suggests a role for vegetable fiber in moderating this response.</p><p>The effect of food order on postprandial glycemia in this study is comparable to the magnitude observed with pharmacological agents that preferentially target postprandial glycemia; acarbose and nateglinide reduce iAUCs by 31% and 64%,&#x02009;respectively, compared with placebo.<xref rid="R13" ref-type="bibr">13 14</xref> In non-insulin treated patients, managed with diet/oral hypoglycemic agents, pramlintide was shown to lower glucose excursions by 57%.<xref rid="R15" ref-type="bibr">15</xref> Limitations of our study include the small sample size and unclear generalizability to meals with different macronutrient compositions and patient populations including those with type&#x000a0;1 diabetes and prediabetes. Further study is needed to explore the mechanisms, including gastric emptying and rates of nutrient absorption with extended follow-up beyond 180&#x02009;min. Strengths of the study include stringent study design and the use of real-world meals that suggest practical utility. In conclusion, our findings suggest that the timing of carbohydrate intake during a meal may have major effects on postprandial glucose excursions comparable in magnitude to many hypoglycemic drugs.</p></sec></body><back><ack><p>APS and LJA are the guarantors of this work and, as such, had full access to all the data in the study and take responsibility for the data and the accuracy of the data analysis.</p></ack><ack><p>The study was supported by Grant UL1 TR000457 of the Clinical and Translational Science Center at Weill Cornell Medical College. DSL is supported by mid-career award K24DK082730 from the National Institute of Diabetes and Digestive and Kidney Diseases.</p></ack><fn-group><fn fn-type="other"><p><bold>Contributors:</bold> APS, DSL and LJA: study concept and design. APS: drafting of the manuscript. APS, JA, SHT, AC and YSZ: conduct of study procedures and data acquisition. RGI and EM: data analysis. APS, JA, SHT and LJA: data interpretation. All the authors contributed to the reviewing and editing of the manuscript. APS and LJA are the guarantors of this work and, as such, had full access to all the data in the study and take responsibility for the data and the accuracy of the data analysis.</p></fn><fn fn-type="other"><p><bold>Funding:</bold> Louis &#x00026; Rachel Rudin Foundation Grant, Diane &#x00026; Darryl Mallah.</p></fn><fn fn-type="other"><p><bold>Disclaimer:</bold> LJA and DSL report receiving royalties for books on nutrition and obesity.</p></fn><fn fn-type="COI-statement"><p><bold>Competing interests:</bold> None declared.</p></fn><fn fn-type="other"><p><bold>Patient consent:</bold> Obtained.</p></fn><fn fn-type="other"><p><bold>Ethics approval:</bold> Weill Cornell Medical College Institutional Review Board.</p></fn><fn fn-type="other"><p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cavalot</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Petrelli</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Traversa</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study</article-title>. <source>J Clin Endocrinol Metab</source>
<year>2006</year>;<volume>91</volume>:<fpage>813</fpage>&#x02013;<lpage>9</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1210/jc.2005-1005">doi:10.1210/jc.2005-1005</ext-link>
<pub-id pub-id-type="pmid">16352690</pub-id></mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Leiter</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Ceriello</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Davidson</surname><given-names>JA</given-names></name>, <etal>et al</etal></person-group>
<article-title>Postprandial glucose regulation: new data and new implications</article-title>. <source>Clin Ther</source>
<year>2005</year>.</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Monnier</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Lapinski</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Colette</surname><given-names>C</given-names></name></person-group>
<article-title>Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c)</article-title>. <source>Diabetes Care</source>
<year>2003</year>;<volume>26</volume>:<fpage>881</fpage>&#x02013;<lpage>5</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2337/diacare.26.3.881">doi:10.2337/diacare.26.3.881</ext-link>
<pub-id pub-id-type="pmid">12610053</pub-id></mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Frid</surname><given-names>AH</given-names></name>, <name name-style="western"><surname>Nilsson</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Holst</surname><given-names>JJ</given-names></name>, <etal>et al</etal></person-group>
<article-title>Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects</article-title>. <source>Am J Clin Nutr</source>
<year>2005</year>;<volume>82</volume>:<fpage>69</fpage>.<pub-id pub-id-type="pmid">16002802</pub-id></mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gentilcore</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Chaikomin</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>KL</given-names></name>, <etal>et al</etal></person-group>
<article-title>Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes</article-title>. <source>J Clin Endocrinol Metab</source>
<year>2006</year>;<volume>91</volume>:<fpage>2062</fpage>&#x02013;<lpage>7</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1210/jc.2005-2644">doi:10.1210/jc.2005-2644</ext-link>
<pub-id pub-id-type="pmid">16537685</pub-id></mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Stevens</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Cukier</surname><given-names>K</given-names></name>, <etal>et al</etal></person-group>
<article-title>Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes</article-title>. <source>Diabetes Care</source>
<year>2009</year>;<volume>32</volume>:<fpage>1600</fpage>&#x02013;<lpage>2</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2337/dc09-0723">doi:10.2337/dc09-0723</ext-link>
<pub-id pub-id-type="pmid">19542012</pub-id></mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Jakubowicz</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Froy</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Ahr&#x000e9;n</surname><given-names>B</given-names></name>, <etal>et al</etal></person-group>
<article-title>Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial</article-title>. <source>Diabetologia</source>
<year>2014</year>;<volume>57</volume>:<fpage>1807</fpage>&#x02013;<lpage>11</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00125-014-3305-x">doi:10.1007/s00125-014-3305-x</ext-link>
<pub-id pub-id-type="pmid">25005331</pub-id></mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Nuttall</surname><given-names>FQ</given-names></name>, <name name-style="western"><surname>Gannon</surname><given-names>MC</given-names></name></person-group>
<article-title>Metabolic response of people with type 2 diabetes to a high protein diet</article-title>. <source>Nutr Metab</source>
<year>2004</year>;<volume>1</volume>:<fpage>6</fpage>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1743-7075-1-6">doi:10.1186/1743-7075-1-6</ext-link>
</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chandalia</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Garg</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lutjohann</surname><given-names>D</given-names></name>, <etal>et al</etal></person-group>
<article-title>Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus</article-title>. <source>N Engl J Med</source>
<year>2000</year>;<volume>342</volume>:<fpage>1392</fpage>&#x02013;<lpage>8</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJM200005113421903">doi:10.1056/NEJM200005113421903</ext-link>
<pub-id pub-id-type="pmid">10805824</pub-id></mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Imai</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fukui</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kajiyama</surname><given-names>S</given-names></name></person-group>
<article-title>Effect of eating vegetables before carbohydrates on glucose excursions in patients with type 2 diabetes</article-title>. <source>J Clin Biochem Nutr</source>
<year>2014</year>;<volume>54</volume>:<fpage>7</fpage>&#x02013;<lpage>11</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3164/jcbn.13-67">doi:10.3164/jcbn.13-67</ext-link>
<pub-id pub-id-type="pmid">24426184</pub-id></mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Shukla</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Iliescu</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>CE</given-names></name>, <etal>et al</etal></person-group>
<article-title>Food order Has a significant impact on postprandial glucose and insulin levels</article-title>. <source>Diabetes Care</source>
<year>2015</year>;<volume>38</volume>:<fpage>e98</fpage>&#x02013;<lpage>e99</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2337/dc15-0429">doi:10.2337/dc15-0429</ext-link>
<pub-id pub-id-type="pmid">26106234</pub-id></mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Marathe</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Rayner</surname><given-names>CK</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>KL</given-names></name>, <etal>et al</etal></person-group>
<article-title>Relationships between gastric emptying, postprandial glycemia, and incretin hormones</article-title>. <source>Diabetes Care</source>
<year>2013</year>;<volume>36</volume>:<fpage>1396</fpage>&#x02013;<lpage>405</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2337/dc12-1609">doi:10.2337/dc12-1609</ext-link>
<pub-id pub-id-type="pmid">23613599</pub-id></mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Shimabukuro</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Higa</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Chinen</surname><given-names>I</given-names></name>, <etal>et al</etal></person-group>
<article-title>Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized crossover study</article-title>. <source>J Clin Endocrinol Metab</source>
<year>2006</year>;<volume>91</volume>:<fpage>837</fpage>&#x02013;<lpage>42</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1210/jc.2005-1566">doi:10.1210/jc.2005-1566</ext-link>
<pub-id pub-id-type="pmid">16368744</pub-id></mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gribble</surname><given-names>FM</given-names></name>, <name name-style="western"><surname>Manley</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Levy</surname><given-names>JC</given-names></name></person-group>
<article-title>Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166)</article-title>. <source>Diabetes Care</source>
<year>2001</year>;<volume>24</volume>:<fpage>1221</fpage>&#x02013;<lpage>5</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2337/diacare.24.7.1221">doi:10.2337/diacare.24.7.1221</ext-link>
<pub-id pub-id-type="pmid">11423506</pub-id></mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Thompson</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Gottlieb</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Organ</surname><given-names>K</given-names></name>, <etal>et al</etal></person-group>
<article-title>Pramlintide: a human amylin analogue reduced postprandial plasma glucose, insulin, and C-peptide concentrations in patients with type 2 diabetes</article-title>. <source>Diabet Med</source>
<year>1997</year>;<volume>14</volume>:<fpage>547</fpage>&#x02013;<lpage>55</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/(SICI)1096-9136(199707)14:7&#x0003c;547::AID-DIA390&#x0003e;3.0.CO;2-U">doi:10.1002/(SICI)1096-9136(199707)14:7&#x0003c;547::AID-DIA390&#x0003e;3.0.CO;2-U</ext-link>
<pub-id pub-id-type="pmid">9223392</pub-id></mixed-citation></ref></ref-list></back></article>